SEC Form 4 · accession 0001871145-26-000006
Olema Pharmaceuticals, Inc. · OLMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason O'Byrne
Officer — CHIEF FINANCIAL OFFICER
Period of report
Sep 1, 2026
Accepted (ET)
Sep 2, 2026 · 4:30 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001750284
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $10.56 | Sep 1, 2026 | A | 650,000 | A | — | Aug 31, 2036 | Common Stock | 650,000 | 650,000 | D |
Explanation of responses
- F125% of the shares subject to the option vest on August 11, 2027 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.